$CTLT
Catalent, Inc.

2024 Q2 Form 10-Q Financial Statement

#000159678323000186 Filed on December 08, 2023

View on sec.gov

Income Statement

Concept 2024 Q2 2023 Q4 2023 Q3
Revenue $1.301B $1.032B $982.0M
YoY Change 21.82% -10.18% -3.91%
Cost Of Revenue $917.0M $871.0M $813.0M
YoY Change 10.08% 14.3% 6.41%
Gross Profit $384.0M $161.0M $169.0M
YoY Change 63.4% -58.4% -34.5%
Gross Profit Margin 29.52% 15.6% 17.21%
Selling, General & Admin $266.0M $239.0M $205.0M
YoY Change 21.46% 5.75% 4.59%
% of Gross Profit 69.27% 148.45% 121.3%
Research & Development $4.000M $4.000M
YoY Change 0.0% -20.0%
% of Gross Profit 2.48% 2.37%
Depreciation & Amortization $130.0M $121.0M $112.0M
YoY Change 14.04% 17.48% 13.13%
% of Gross Profit 33.85% 75.16% 66.27%
Operating Expenses $278.0M $272.0M $209.0M
YoY Change -17.01% 18.26% 3.98%
Operating Profit $106.0M -$111.0M -$726.0M
YoY Change -206.0% -180.43% -1310.0%
Interest Expense -$65.00M -$66.00M -$70.00M
YoY Change 20.37% 200.0% 25.0%
% of Operating Profit -61.32%
Other Income/Expense, Net -$3.000M -$4.000M -$13.00M
YoY Change -175.0% -117.39% -48.0%
Pretax Income $38.00M -$181.0M -$797.0M
YoY Change -125.33% -258.77% -26666.67%
Income Tax $15.00M $23.00M -$38.00M
% Of Pretax Income 39.47%
Net Earnings $23.00M -$204.0M -$759.0M
YoY Change -126.74% -351.85%
Net Earnings / Revenue 1.77% -19.77% -77.29%
Basic Earnings Per Share -$1.13 -$4.19
Diluted Earnings Per Share $0.13 -$1.12 -$4.19
COMMON SHARES
Basic Shares Outstanding 181.0M shares 180.6M shares 181.0M shares
Diluted Shares Outstanding 182.0M shares 181.0M shares

Balance Sheet

Concept 2024 Q2 2023 Q4 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $289.0M $229.0M $209.0M
YoY Change 3.21% -51.28% -39.42%
Cash & Equivalents $289.0M $229.0M $209.0M
Short-Term Investments
Other Short-Term Assets $813.0M $742.0M $34.00M
YoY Change 23.56% 1157.63% -42.37%
Inventory $574.0M $775.0M $796.0M
Prepaid Expenses $46.00M $58.00M $63.00M
Receivables $921.0M $832.0M $830.0M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $2.917B $2.578B $2.614B
YoY Change 0.0% -11.65% -3.11%
LONG-TERM ASSETS
Property, Plant & Equipment $3.643B $3.777B $3.723B
YoY Change -1.51% 5.53% 17.56%
Goodwill $2.333B $2.351B $2.316B
YoY Change -23.23% -26.87% -20.93%
Intangibles $841.0M $911.0M $942.0M
YoY Change -14.18% -12.82% -7.37%
Long-Term Investments
YoY Change
Other Assets $3.513B $3.641B $328.0M
YoY Change -20.23% 986.87% -6.02%
Total Long-Term Assets $7.591B $7.418B $7.409B
YoY Change 0.0% -9.86% -1.31%
TOTAL ASSETS
Total Short-Term Assets $2.917B $2.578B $2.614B
Total Long-Term Assets $7.591B $7.418B $7.409B
Total Assets $10.51B $9.996B $10.02B
YoY Change 0.0% -10.33% -1.78%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $361.0M $407.0M $367.0M
YoY Change -15.46% 10.9% -3.17%
Accrued Expenses $622.0M $589.0M $320.0M
YoY Change 14.34% 85.22% 13.88%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $48.00M $46.00M $624.0M
YoY Change -91.04% -92.72% 488.68%
Total Short-Term Liabilities $1.098B $1.042B $1.534B
YoY Change 0.0% -31.72% 62.67%
LONG-TERM LIABILITIES
Long-Term Debt $4.857B $4.959B $4.322B
YoY Change 12.61% 17.48% 5.47%
Other Long-Term Liabilities $261.0M $306.0M $159.0M
YoY Change -20.18% 86.59% 4.61%
Total Long-Term Liabilities $5.118B $5.265B $159.0M
YoY Change 10.3% 3110.37% 4.61%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.098B $1.042B $1.534B
Total Long-Term Liabilities $5.118B $5.265B $159.0M
Total Liabilities $5.733B $6.307B $6.182B
YoY Change 0.0% 1.15% 12.3%
SHAREHOLDERS EQUITY
Retained Earnings $518.0M -$703.0M -$497.0M
YoY Change 0.0% -213.57% -192.38%
Common Stock $4.787B $4.742B $4.724B
YoY Change 1.83% 1.2% 1.07%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $4.775B $3.689B $3.841B
YoY Change
Total Liabilities & Shareholders Equity $10.51B $9.996B $10.02B
YoY Change 0.0% -10.33% -1.78%

Cashflow Statement

Concept 2024 Q2 2023 Q4 2023 Q3
OPERATING ACTIVITIES
Net Income $23.00M -$204.0M -$759.0M
YoY Change -126.74% -351.85%
Depreciation, Depletion And Amortization $130.0M $121.0M $112.0M
YoY Change 14.04% 17.48% 13.13%
Cash From Operating Activities $214.0M $112.0M -$70.00M
YoY Change 9.18% -47.66% -23.91%
INVESTING ACTIVITIES
Capital Expenditures $75.00M $94.00M $84.00M
YoY Change -38.02% -44.05% -43.62%
Acquisitions
YoY Change
Other Investing Activities $1.000M -$1.000M $0.00
YoY Change -99.77% -100.0%
Cash From Investing Activities -$74.00M -$95.00M -$84.00M
YoY Change -38.84% -84.38% -27.59%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $35.00M
YoY Change 400.0%
Cash From Financing Activities -10.00M -14.00M $98.00M
YoY Change -80.39% -102.68% 32.43%
NET CHANGE
Cash From Operating Activities 214.0M 112.0M -$70.00M
Cash From Investing Activities -74.00M -95.00M -$84.00M
Cash From Financing Activities -10.00M -14.00M $98.00M
Net Change In Cash 130.0M 3.000M -$71.00M
YoY Change 441.67% -97.67% -57.74%
FREE CASH FLOW
Cash From Operating Activities $214.0M $112.0M -$70.00M
Capital Expenditures $75.00M $94.00M $84.00M
Free Cash Flow $139.0M $18.00M -$154.0M
YoY Change 85.33% -60.87% -36.1%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000 shares
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
181000000 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
180000000 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
180000000 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
179000000 shares
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000 shares
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000 shares
CY2023Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
48000000 usd
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
46000000 usd
CY2023Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1647000000 usd
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1596000000 usd
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
362000000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
9000000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Other Longterm Incentive Plans Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition
21000000 usd
us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
9000000 usd
us-gaap Dividends Preferred Stock
DividendsPreferredStock
6000000 usd
us-gaap Net Income Loss
NetIncomeLoss
0 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-33000000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
5181000000 usd
CY2024Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
626000000 usd
CY2024Q2 us-gaap Assets Current
AssetsCurrent
2917000000 usd
CY2024Q2 us-gaap Assets
Assets
10508000000 usd
CY2024Q2 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
646000000 usd
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
1098000000 usd
CY2024Q2 us-gaap Deferred Tax Liabilities Tax Deferred Income
DeferredTaxLiabilitiesTaxDeferredIncome
197000000 usd
CY2024Q2 us-gaap Liabilities
Liabilities
5733000000 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
518000000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
4775000000 usd
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
10508000000 usd
CY2023Q3 dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
CY2023Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
689000000 usd
CY2022Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 usd
CY2023Q3 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
1000000 usd
CY2022Q3 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
2000000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-726000000 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
60000000 usd
CY2023Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-58000000 usd
CY2022Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-32000000 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-13000000 usd
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-25000000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-759000000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-797000000 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
3000000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-38000000 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3000000 usd
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-4.19
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-4.19
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-759000000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-135000000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
0 usd
CY2023Q3 ctlt Oci Debt Securities Derivative And Hedge Gain Loss After Adjustment And Tax
OCIDebtSecuritiesDerivativeAndHedgeGainLossAfterAdjustmentAndTax
5000000 usd
CY2022Q3 ctlt Oci Debt Securities Derivative And Hedge Gain Loss After Adjustment And Tax
OCIDebtSecuritiesDerivativeAndHedgeGainLossAfterAdjustmentAndTax
14000000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-34000000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-120000000 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-793000000 usd
CY2022Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-120000000 usd
CY2023Q3 dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
209000000 usd
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
280000000 usd
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
48000000 usd
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
46000000 usd
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
830000000 usd
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1002000000 usd
CY2023Q3 us-gaap Inventory Net
InventoryNet
796000000 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
777000000 usd
CY2023Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
779000000 usd
CY2023Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
633000000 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
2614000000 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
2692000000 usd
CY2023Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1647000000 usd
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1596000000 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3723000000 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3682000000 usd
CY2023Q3 us-gaap Goodwill
Goodwill
2316000000 usd
CY2023Q2 us-gaap Goodwill
Goodwill
3039000000 usd
CY2023Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
942000000 usd
CY2023Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
980000000 usd
CY2023Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
100000000 usd
CY2023Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
55000000 usd
CY2023Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
328000000 usd
CY2023Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
329000000 usd
CY2023Q3 us-gaap Assets
Assets
10023000000 usd
CY2023Q2 us-gaap Assets
Assets
10777000000 usd
CY2023Q3 us-gaap Debt Current
DebtCurrent
624000000 usd
CY2023Q2 us-gaap Debt Current
DebtCurrent
536000000 usd
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
367000000 usd
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
424000000 usd
CY2023Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
543000000 usd
CY2023Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
570000000 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
1534000000 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
1530000000 usd
CY2023Q3 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
4322000000 usd
CY2023Q2 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
4313000000 usd
CY2023Q3 us-gaap Defined Benefit Pension Plan Liabilities Noncurrent
DefinedBenefitPensionPlanLiabilitiesNoncurrent
99000000 usd
CY2023Q2 us-gaap Defined Benefit Pension Plan Liabilities Noncurrent
DefinedBenefitPensionPlanLiabilitiesNoncurrent
100000000 usd
CY2023Q3 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
68000000 usd
CY2023Q2 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
76000000 usd
CY2023Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
159000000 usd
CY2023Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
147000000 usd
CY2023Q3 us-gaap Liabilities
Liabilities
6182000000 usd
CY2023Q2 us-gaap Liabilities
Liabilities
6166000000 usd
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
181000000 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
180000000 shares
CY2023Q3 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
2000000 usd
CY2023Q2 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
2000000 usd
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000 shares
CY2023Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q3 us-gaap Preferred Stock Value Outstanding
PreferredStockValueOutstanding
0 usd
CY2023Q2 us-gaap Preferred Stock Value Outstanding
PreferredStockValueOutstanding
0 usd
CY2023Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
4724000000 usd
CY2023Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
4701000000 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-497000000 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
262000000 usd
CY2023Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-388000000 usd
CY2023Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-354000000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
3841000000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
4611000000 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
10023000000 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
10777000000 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4611000000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
0 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
19000000 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
1000000 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition
3000000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-759000000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-759000000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-34000000 usd
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3841000000 usd
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4795000000 usd
CY2022Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
0 usd
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
19000000 usd
CY2022Q3 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
2000000 usd
CY2023Q3 us-gaap Profit Loss
ProfitLoss
-759000000 usd
CY2022Q3 us-gaap Profit Loss
ProfitLoss
0 usd
CY2023Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
112000000 usd
CY2022Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
99000000 usd
CY2023Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
689000000 usd
CY2022Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 usd
CY2023Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-9000000 usd
CY2022Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-27000000 usd
CY2023Q3 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
2000000 usd
CY2022Q3 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
2000000 usd
CY2023Q3 us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
1000000 usd
CY2022Q3 us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
2000000 usd
CY2023Q3 us-gaap Share Based Compensation
ShareBasedCompensation
19000000 usd
CY2022Q3 us-gaap Share Based Compensation
ShareBasedCompensation
19000000 usd
CY2023Q3 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
44000000 usd
CY2022Q3 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
4000000 usd
CY2023Q3 ctlt Provision For Bad Debts And Inventory
ProvisionForBadDebtsAndInventory
10000000 usd
CY2022Q3 ctlt Provision For Bad Debts And Inventory
ProvisionForBadDebtsAndInventory
28000000 usd
CY2023Q3 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-160000000 usd
CY2022Q3 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-31000000 usd
CY2023Q3 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
31000000 usd
CY2022Q3 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
85000000 usd
CY2023Q3 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-73000000 usd
CY2022Q3 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-52000000 usd
CY2023Q3 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
163000000 usd
CY2022Q3 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
155000000 usd
CY2023Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-70000000 usd
CY2022Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-92000000 usd
CY2023Q3 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
84000000 usd
CY2022Q3 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
149000000 usd
CY2023Q3 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
0 usd
CY2022Q3 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
24000000 usd
CY2023Q3 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
1000000 usd
CY2022Q3 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
6000000 usd
CY2023Q3 us-gaap Proceeds From Sale And Maturity Of Other Investments
ProceedsFromSaleAndMaturityOfOtherInvestments
1000000 usd
CY2022Q3 us-gaap Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
3000000 usd
CY2023Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-84000000 usd
CY2022Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-116000000 usd
CY2023Q3 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
115000000 usd
CY2022Q3 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
75000000 usd
CY2023Q3 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
35000000 usd
CY2022Q3 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
7000000 usd
CY2023Q3 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
1000000 usd
CY2022Q3 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 usd
CY2023Q3 ctlt Proceeds From Tax Withholding Obligations
ProceedsFromTaxWithholdingObligations
0 usd
CY2022Q3 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
2000000 usd
CY2023Q3 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1000000 usd
CY2022Q3 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1000000 usd
CY2023Q3 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
18000000 usd
CY2022Q3 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
3000000 usd
CY2023Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
98000000 usd
CY2022Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
74000000 usd
CY2023Q3 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-15000000 usd
CY2022Q3 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-34000000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-71000000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-168000000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
449000000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
209000000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
281000000 usd
CY2023Q3 us-gaap Interest Paid Net
InterestPaidNet
65000000 usd
CY2022Q3 us-gaap Interest Paid Net
InterestPaidNet
46000000 usd
CY2023Q3 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
19000000 usd
CY2022Q3 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
11000000 usd
CY2023Q3 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
21000000 usd
CY2022Q3 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
22000000 usd
CY2023Q3 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentrations of Credit Risk and Major Customers</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Concentration of credit risk, with respect to accounts receivable, is limited due to the large number of customers and their dispersion across different geographic areas. The customers are primarily concentrated in the pharmaceutical, biopharmaceutical and consumer products industries. The Company does not normally require collateral or any other security to support credit sales. The Company performs ongoing credit evaluations of its customers’ financial conditions and maintains reserves for credit losses. Such losses historically have been within the Company’s expectations. </span></div>As of September 30, 2023 and June 30, 2023, the Company had one customer that represented 30% and 20%, respectively, of its aggregate net trade receivables and current contract asset values, primarily associated with the Company's Biologics segment. After performing a risk assessment of this customer, the Company has determined that a reserve is not warranted as of September 30, 2023. Additionally, the Company had one customer in its Biologics segment that represented approximately 16% of consolidated net revenue during the three months ended September 30, 2023. That customer did not exceed 10% of net revenue during the three months ended September 30, 2022.
CY2023Q3 ctlt Concentration Risk Trade Receivables And Current Contract Asset Percentage
ConcentrationRiskTradeReceivablesAndCurrentContractAssetPercentage
0.30 rate
CY2023Q2 ctlt Concentration Risk Trade Receivables And Current Contract Asset Percentage
ConcentrationRiskTradeReceivablesAndCurrentContractAssetPercentage
0.20 rate
CY2023Q3 us-gaap Segment Reporting Disclosure Of Major Customers
SegmentReportingDisclosureOfMajorCustomers
16
CY2022Q3 us-gaap Segment Reporting Disclosure Of Major Customers
SegmentReportingDisclosureOfMajorCustomers
10%
CY2023Q3 us-gaap Cost Depreciation Amortization And Depletion
CostDepreciationAmortizationAndDepletion
78000000 usd
CY2022Q3 us-gaap Cost Depreciation Amortization And Depletion
CostDepreciationAmortizationAndDepletion
66000000 usd
CY2023Q3 dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
CY2023Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
34000000 usd
CY2022Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
33000000 usd
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4000000 usd
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5000000 usd
CY2023Q3 dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
CY2022Q3 us-gaap Revenues
Revenues
1022000000 usd
CY2023Q3 ctlt Eliminationofrevenueattributabletomultiplelocations
Eliminationofrevenueattributabletomultiplelocations
-25000000 usd
CY2022Q3 ctlt Eliminationofrevenueattributabletomultiplelocations
Eliminationofrevenueattributabletomultiplelocations
-31000000 usd
CY2023Q3 us-gaap Revenues
Revenues
982000000 usd
CY2022Q3 us-gaap Revenues
Revenues
1022000000 usd
CY2023Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
180000000 usd
CY2023Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
189000000 usd
CY2023Q3 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
-75000000 usd
CY2023Q3 dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
CY2023Q3 dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
CY2023Q3 ctlt Contract With Customer Asset
ContractWithCustomerAsset
536000000 usd
CY2023Q2 ctlt Contract With Customer Asset
ContractWithCustomerAsset
417000000 usd
CY2023Q3 dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
CY2023Q3 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
119000000 usd
CY2023Q3 ctlt Percentage Increase Decrease In Contract With Customer Asset
PercentageIncreaseDecreaseInContractWithCustomerAsset
0.29 usd
CY2023Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
545000000 usd
CY2023Q3 dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
CY2023Q3 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-34000000 usd
CY2023Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
689000000 usd
CY2023Q3 us-gaap Goodwill
Goodwill
2316000000 usd
CY2023Q3 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
899000000 usd
CY2023Q3 ctlt Goodwill Inputs Percentage Long Term Revenue Growth Rate
GoodwillInputsPercentageLongTermRevenueGrowthRate
0.035
CY2023Q3 ctlt Goodwill Inputs Percentage Discount Rate Minimum
GoodwillInputsPercentageDiscountRateMinimum
0.09
CY2023Q3 ctlt Goodwill Inputs Percentage Discount Rate Maximum
GoodwillInputsPercentageDiscountRateMaximum
0.10
CY2023Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
689000000 usd
CY2023Q3 dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
CY2023Q3 dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
CY2023Q3 us-gaap Debt And Capital Lease Obligations
DebtAndCapitalLeaseObligations
4946000000 usd
CY2023Q2 us-gaap Debt And Capital Lease Obligations
DebtAndCapitalLeaseObligations
4849000000 usd
CY2023Q3 us-gaap Debt Current
DebtCurrent
624000000 usd
CY2023Q2 us-gaap Debt Current
DebtCurrent
536000000 usd
CY2023Q3 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
4322000000 usd
CY2023Q2 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
4313000000 usd
CY2023Q3 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
115000000 usd
CY2023Q3 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
30000000 usd
CY2023Q3 us-gaap Sale And Leaseback Transaction Gain Loss Net
SaleAndLeasebackTransactionGainLossNet
15000000 usd
CY2023Q3 dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
CY2023Q3 us-gaap Debt Instrument Unused Borrowing Capacity Amount
DebtInstrumentUnusedBorrowingCapacityAmount
509000000 usd
CY2023Q3 us-gaap Other Short Term Borrowings
OtherShortTermBorrowings
585000000 usd
CY2023Q3 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
6000000 usd
CY2022Q3 us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
1000000 usd
CY2023Q3 ctlt Multiemployer Plans Estimated Discounted Valueof Future Employer Contributions
MultiemployerPlansEstimatedDiscountedValueofFutureEmployerContributions
38000000 usd
CY2023Q3 us-gaap Defined Benefit Plan Service Cost
DefinedBenefitPlanServiceCost
1000000 usd
CY2022Q3 us-gaap Defined Benefit Plan Service Cost
DefinedBenefitPlanServiceCost
1000000 usd
CY2023Q3 us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
3000000 usd
CY2022Q3 us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
2000000 usd
CY2023Q3 dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-759000000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
0 usd
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
181000000 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
180000000 shares
CY2023Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2022Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1000000 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
181000000 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
181000000 shares
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-4.19
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-4.19
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
CY2023Q3 us-gaap Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
2000000 usd
CY2022Q3 us-gaap Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
2000000 usd
CY2023Q3 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-12000000 usd
CY2022Q3 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-24000000 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1000000 usd
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1000000 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-13000000 usd
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-25000000 usd
CY2023Q3 us-gaap Restructuring And Related Cost Number Of Positions Eliminated
RestructuringAndRelatedCostNumberOfPositionsEliminated
50 employees
CY2023Q3 us-gaap Restructuring And Related Cost Expected Cost1
RestructuringAndRelatedCostExpectedCost1
2000000 usd
CY2023Q3 us-gaap Severance Costs1
SeveranceCosts1
2000000 usd
CY2022Q3 us-gaap Severance Costs1
SeveranceCosts1
2000000 usd
CY2023Q3 us-gaap Business Exit Costs1
BusinessExitCosts1
0 usd
CY2022Q3 us-gaap Business Exit Costs1
BusinessExitCosts1
2000000 usd
CY2023Q3 us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
2000000 usd
CY2022Q3 us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
4000000 usd
CY2023Q3 us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
2000000 usd
CY2022Q3 us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
4000000 usd
CY2023Q2 us-gaap Restructuring Reserve
RestructuringReserve
19000000 usd
CY2023Q3 us-gaap Restructuring And Related Cost Incurred Cost
RestructuringAndRelatedCostIncurredCost
2000000 usd
CY2023Q3 us-gaap Payments For Restructuring
PaymentsForRestructuring
9000000 usd
CY2023Q3 us-gaap Restructuring Reserve
RestructuringReserve
12000000 usd
CY2023Q3 dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
CY2023Q3 us-gaap Translation Adjustment For Net Investment Hedge Increase Decrease Gross Of Tax
TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax
32000000 usd
CY2022Q3 us-gaap Translation Adjustment For Net Investment Hedge Increase Decrease Gross Of Tax
TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax
81000000 usd
CY2022Q3 us-gaap Translation Adjustment For Net Investment Hedge Increase Decrease Gross Of Tax
TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax
81000000 usd
CY2023Q3 dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
CY2023Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
129000000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Before Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax
5000000 usd
CY2023Q3 us-gaap Interest Rate Cash Flow Hedge Asset At Fair Value
InterestRateCashFlowHedgeAssetAtFairValue
67000000 usd
CY2023Q2 us-gaap Interest Rate Cash Flow Hedge Liability At Fair Value
InterestRateCashFlowHedgeLiabilityAtFairValue
62000000 usd
CY2023Q3 us-gaap Interest Rate Cash Flow Hedge Asset At Fair Value
InterestRateCashFlowHedgeAssetAtFairValue
67000000 usd
CY2023Q3 ctlt Trading Securities At Fair Value
TradingSecuritiesAtFairValue
2000000 usd
CY2023Q2 us-gaap Interest Rate Cash Flow Hedge Asset At Fair Value
InterestRateCashFlowHedgeAssetAtFairValue
62000000 usd
CY2023Q2 ctlt Trading Securities At Fair Value
TradingSecuritiesAtFairValue
1000000 usd
CY2023Q2 ctlt Uncertain Tax Positions Including Income Tax Penalties And Interest Accrued
UncertainTaxPositionsIncludingIncomeTaxPenaltiesAndInterestAccrued
4000000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-38000000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-797000000 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3000000 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
3000000 usd
CY2023Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
53000000 usd
CY2023Q3 us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
2000000 usd
CY2023Q3 dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
CY2023Q3 ctlt Multiemployer Plans Estimated Annual Cash Contribution
MultiemployerPlansEstimatedAnnualCashContribution
2000000 usd
CY2022Q3 ctlt Multiemployer Plans Estimated Annual Cash Contribution
MultiemployerPlansEstimatedAnnualCashContribution
2000000 usd
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000 shares
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000 shares
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q3 us-gaap Translation Adjustment For Net Investment Hedge Increase Decrease Gross Of Tax
TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax
32000000 usd
CY2022Q3 us-gaap Translation Adjustment For Net Investment Hedge Increase Decrease Gross Of Tax
TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax
81000000 usd
CY2022Q3 us-gaap Translation Adjustment For Net Investment Hedge Increase Decrease Gross Of Tax
TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax
81000000 usd
CY2023Q3 ctlt Other Comprehensive Income Loss Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax Longterm Intercompany Loans
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTaxLongtermIntercompanyLoans
-16000000 usd
CY2022Q3 ctlt Other Comprehensive Income Loss Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax Longterm Intercompany Loans
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTaxLongtermIntercompanyLoans
-41000000 usd
CY2023Q3 us-gaap Translation Adjustment Functional To Reporting Currency Increase Decrease Gross Of Tax
TranslationAdjustmentFunctionalToReportingCurrencyIncreaseDecreaseGrossOfTax
-65000000 usd
CY2022Q3 us-gaap Translation Adjustment Functional To Reporting Currency Increase Decrease Gross Of Tax
TranslationAdjustmentFunctionalToReportingCurrencyIncreaseDecreaseGrossOfTax
-160000000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
-49000000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
-120000000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
-10000000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
15000000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-39000000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-135000000 usd
CY2023Q3 ctlt Derivative Other Comprehensive Income Loss Net Gain Loss Before Tax
DerivativeOtherComprehensiveIncomeLossNetGainLossBeforeTax
6000000 usd
CY2022Q3 ctlt Derivative Other Comprehensive Income Loss Net Gain Loss Before Tax
DerivativeOtherComprehensiveIncomeLossNetGainLossBeforeTax
18000000 usd
CY2023Q3 ctlt Other Comprehensive Income Loss Derivative And Hedge Total Before Tax
OtherComprehensiveIncomeLossDerivativeAndHedgeTotalBeforeTax
6000000 usd
CY2022Q3 ctlt Other Comprehensive Income Loss Derivative And Hedge Total Before Tax
OtherComprehensiveIncomeLossDerivativeAndHedgeTotalBeforeTax
18000000 usd
CY2023Q3 ctlt Other Comprehensive Income Loss Derivative And Hedge After Reclassification Adjustment Tax
OtherComprehensiveIncomeLossDerivativeAndHedgeAfterReclassificationAdjustmentTax
1000000 usd
CY2022Q3 ctlt Other Comprehensive Income Loss Derivative And Hedge After Reclassification Adjustment Tax
OtherComprehensiveIncomeLossDerivativeAndHedgeAfterReclassificationAdjustmentTax
4000000 usd
CY2023Q3 ctlt Oci Debt Securities Derivative And Hedge Gain Loss After Adjustment And Tax
OCIDebtSecuritiesDerivativeAndHedgeGainLossAfterAdjustmentAndTax
5000000 usd
CY2022Q3 ctlt Oci Debt Securities Derivative And Hedge Gain Loss After Adjustment And Tax
OCIDebtSecuritiesDerivativeAndHedgeGainLossAfterAdjustmentAndTax
14000000 usd
CY2023Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-354000000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
-34000000 usd
CY2023Q3 us-gaap Other Comprehensive Income Other Net Of Tax
OtherComprehensiveIncomeOtherNetOfTax
-34000000 usd
CY2022Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-394000000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
-121000000 usd
CY2022Q3 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
1000000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
1000000 usd
CY2022Q3 us-gaap Other Comprehensive Income Other Net Of Tax
OtherComprehensiveIncomeOtherNetOfTax
-120000000 usd
CY2022Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-514000000 usd
CY2023Q3 ctlt Segment Reporting Information Unallocated Expense
SegmentReportingInformationUnallocatedExpense
777000000 usd
CY2022Q3 ctlt Segment Reporting Information Unallocated Expense
SegmentReportingInformationUnallocatedExpense
87000000 usd
CY2023Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
112000000 usd
CY2022Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
99000000 usd
CY2023Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-58000000 usd
CY2022Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-32000000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-38000000 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3000000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-759000000 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
0 usd
CY2023Q3 ctlt Impairment Charges And Gain Loss On Sale Of Assets
ImpairmentChargesAndGainLossOnSaleOfAssets
-1000000 usd
CY2022Q3 ctlt Impairment Charges And Gain Loss On Sale Of Assets
ImpairmentChargesAndGainLossOnSaleOfAssets
-2000000 usd
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
19000000 usd
CY2022Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
19000000 usd
CY2023Q3 ctlt Restructuring And Other Special Items
RestructuringAndOtherSpecialItems
23000000 usd
CY2022Q3 ctlt Restructuring And Other Special Items
RestructuringAndOtherSpecialItems
9000000 usd
CY2023Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
689000000 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-13000000 usd
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-25000000 usd
CY2023Q3 ctlt Non Allocated Corporate Costs Net
NonAllocatedCorporateCostsNet
34000000 usd
CY2022Q3 ctlt Non Allocated Corporate Costs Net
NonAllocatedCorporateCostsNet
36000000 usd
CY2023Q3 ctlt Segment Reporting Information Unallocated Expense
SegmentReportingInformationUnallocatedExpense
777000000 usd
CY2022Q3 ctlt Segment Reporting Information Unallocated Expense
SegmentReportingInformationUnallocatedExpense
87000000 usd
CY2023Q3 us-gaap Assets
Assets
10023000000 usd
CY2023Q2 us-gaap Assets
Assets
10777000000 usd
CY2023Q3 dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
CY2023Q3 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
781000000 usd
CY2023Q2 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
781000000 usd
CY2023Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
186000000 usd
CY2023Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
186000000 usd
CY2023Q3 us-gaap Inventory Gross
InventoryGross
967000000 usd
CY2023Q2 us-gaap Inventory Gross
InventoryGross
967000000 usd
CY2023Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
171000000 usd
CY2023Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
190000000 usd
CY2023Q3 us-gaap Inventory Net
InventoryNet
796000000 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
777000000 usd
CY2023Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
63000000 usd
CY2023Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
53000000 usd
CY2023Q3 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
519000000 usd
CY2023Q2 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
399000000 usd
CY2023Q3 ctlt Spare Parts
SpareParts
26000000 usd
CY2023Q2 ctlt Spare Parts
SpareParts
24000000 usd
CY2023Q3 us-gaap Prepaid Taxes
PrepaidTaxes
89000000 usd
CY2023Q2 us-gaap Prepaid Taxes
PrepaidTaxes
77000000 usd
CY2023Q3 us-gaap Value Added Tax Receivable
ValueAddedTaxReceivable
48000000 usd
CY2023Q2 us-gaap Value Added Tax Receivable
ValueAddedTaxReceivable
38000000 usd
CY2023Q3 us-gaap Other Assets Current
OtherAssetsCurrent
34000000 usd
CY2023Q2 us-gaap Other Assets Current
OtherAssetsCurrent
42000000 usd
CY2023Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
779000000 usd
CY2023Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
633000000 usd
CY2023Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
179000000 usd
CY2023Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
167000000 usd
CY2023Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
123000000 usd
CY2023Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
160000000 usd
CY2023Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
147000000 usd
CY2023Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
134000000 usd
CY2023Q3 ctlt Accrued Operating Lease Liabilities
AccruedOperatingLeaseLiabilities
11000000 usd
CY2023Q2 ctlt Accrued Operating Lease Liabilities
AccruedOperatingLeaseLiabilities
11000000 usd
CY2023Q3 ctlt Accrued Restructuring Reserve
AccruedRestructuringReserve
12000000 usd
CY2023Q2 ctlt Accrued Restructuring Reserve
AccruedRestructuringReserve
19000000 usd
CY2023Q3 us-gaap Interest Payable Current
InterestPayableCurrent
27000000 usd
CY2023Q2 us-gaap Interest Payable Current
InterestPayableCurrent
35000000 usd
CY2023Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
44000000 usd
CY2023Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
44000000 usd
CY2023Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
543000000 usd
CY2023Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
570000000 usd
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
46000000 usd
CY2023Q3 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
3000000 usd
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
1000000 usd
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
48000000 usd
CY2023Q4 us-gaap Restructuring And Related Cost Expected Cost1
RestructuringAndRelatedCostExpectedCost1
25 usd
CY2023Q3 dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
CY2023Q3 dei Document Period End Date
DocumentPeriodEndDate
2023-09-30

Files In Submission

Name View Source Status
ctlt-20230930_cal.xml Edgar Link unprocessable
ctlt-20230930_def.xml Edgar Link unprocessable
0001596783-23-000186-index-headers.html Edgar Link pending
0001596783-23-000186-index.html Edgar Link pending
0001596783-23-000186.txt Edgar Link pending
0001596783-23-000186-xbrl.zip Edgar Link pending
catalent-20230930xex311.htm Edgar Link pending
catalent-20230930xex312.htm Edgar Link pending
catalent-20230930xex321.htm Edgar Link pending
catalent-20230930xex322.htm Edgar Link pending
ctlt-20230930.htm Edgar Link pending
ctlt-20230930.xsd Edgar Link pending
ctlt-20230930_g1.jpg Edgar Link pending
ctlt-20230930_g2.jpg Edgar Link pending
ctlt-20230930_g3.jpg Edgar Link pending
ctlt-20230930_g4.jpg Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
ctlt-20230930_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
ctlt-20230930_pre.xml Edgar Link unprocessable
ctlt-20230930_htm.xml Edgar Link completed
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
R9999.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending